Sara Jane Webb, PhD

Personal Statement

My research focuses on understanding the development of neural circuits that contributing to and underlie social development. Our lab uses a number of different tools: primarily electroencephalography (EEG) and event-related potentials (ERPs), but also eye tracking, cardiophysiology (EKG), neuroimaging, and behavioral measures to study how infants, children, and adults perceive, attend and learn about their social environment. Our projects also focus on the development and validation of biomarkers that may be used to understand the course of development and treatment response in children with disruption in social and communication function such as autism spectrum disorder, 16p11.2 deletion syndrome, and other neurodevelopmental disorders.


Cognitive Neuroscience, University of Illinois, Beckman Institute for Advanced Science, 2001
Clinical Electrophysiology, University of Washington, Center on Human Development & Disability, 2001-2004
PhD, Child Psychology, University of Minnesota, Institute of Child Development, 1996-2001
BA, Psychology, Yale University, 1992-1996

Department Affiliations

Other Affiliations

Seattle Children’s Research Institute
Center on Child Health, Behavior, & Development

Recent Publications

Evaluation of clinical assessments of social abilities for use in autism clinical trials by the autism biomarkers consortium for clinical trials.
(2023 Mar 16)
Autism Res
Faja S, Sabatos-DeVito M, Sridhar A, Kuhn JL, Nikolaeva JI, Sugar CA, Webb SJ, Bernier RA, Sikich L, Hellemann G, Senturk D, Naples AJ, Shic F, Levin AR, Seow HA, Dziura JD, Jeste SS, Chawarska K, Nelson CA 3rd, Dawson G, McPartland JC, Autism Biomarkers Consortium for Clinical Trials

Linear discriminant analysis of phenotypic data for classifying autism spectrum disorder by diagnosis and sex.
Front Neurosci 16(): 1040085
Jacokes Z, Jack A, Sullivan CAW, Aylward E, Bookheimer SY, Dapretto M, Bernier RA, Geschwind DH, Sukhodolsky DG, McPartland JC, Webb SJ, Torgerson CM, Eilbott J, Kenworthy L, Pelphrey KA, Van Horn JD, GENDAAR Consortium

Concomitant medication use in children with autism spectrum disorder: Data from the Autism Biomarkers Consortium for Clinical Trials.
(2022 Sep 9)
Shurtz L, Schwartz C, DiStefano C, McPartland JC, Levin AR, Dawson G, Kleinhans NM, Faja S, Webb SJ, Shic F, Naples AJ, Seow H, Bernier RA, Chawarska K, Sugar CA, Dziura J, Senturk D, Santhosh M, Jeste SS

The Autism Biomarkers Consortium for Clinical Trials: Initial Evaluation of a Battery of Candidate EEG Biomarkers.
(2023 Jan 1)
Am J Psychiatry 180(1): 41-49
Webb SJ, Naples AJ, Levin AR, Hellemann G, Borland H, Benton J, Carlos C, McAllister T, Santhosh M, Seow H, Atyabi A, Bernier R, Chawarska K, Dawson G, Dziura J, Faja S, Jeste S, Murias M, Nelson CA, Sabatos-DeVito M, Senturk D, Shic F, Sugar CA, McPartland JC

Attention Allocation During Exploration of Visual Arrays in ASD: Results from the ABC-CT Feasibility Study.
(2022 Jun 3)
J Autism Dev Disord
Tsang T, Naples AJ, Barney EC, Xie M, Bernier R, Dawson G, Dziura J, Faja S, Jeste SS, McPartland JC, Nelson CA, Murias M, Seow H, Sugar C, Webb SJ, Shic F, Johnson SP

Show complete publication list »
Edit Profile